Ignite Creation Date:
2025-12-24 @ 6:25 PM
Ignite Modification Date:
2026-01-16 @ 4:02 PM
Study NCT ID:
NCT04398368
Status:
TERMINATED
Last Update Posted:
2023-08-08
First Post:
2020-05-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary Tract Urothelial Cancer Undergoing Radical Nephroureterectomy, GEMINI Study
Sponsor:
Mayo Clinic
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Stage 0a Renal Pelvis and Ureter Cancer AJCC v8 | View |
| None | Stage 0a Renal Pelvis Cancer AJCC v8 | View |
| None | Stage 0a Ureter Cancer AJCC v8 | View |
| None | Stage 0is Renal Pelvis and Ureter Cancer AJCC v8 | View |
| None | Stage 0is Renal Pelvis Cancer AJCC v8 | View |
| None | Stage 0is Ureter Cancer AJCC v8 | View |
| None | Stage I Renal Pelvis and Ureter Cancer AJCC v8 | View |
| None | Stage I Renal Pelvis Cancer AJCC v8 | View |
| None | Stage I Ureter Cancer AJCC v8 | View |
| None | Stage II Renal Pelvis and Ureter Cancer AJCC v8 | View |
| None | Stage II Renal Pelvis Cancer AJCC v8 | View |
| None | Stage II Ureter Cancer AJCC v8 | View |
| None | Stage III Renal Pelvis and Ureter Cancer AJCC v8 | View |
| None | Stage III Renal Pelvis Cancer AJCC v8 | View |
| None | Stage III Ureter Cancer AJCC v8 | View |
| None | Stage IV Renal Pelvis and Ureter Cancer AJCC v8 | View |
| None | Stage IV Renal Pelvis Cancer AJCC v8 | View |
| None | Stage IV Ureter Cancer AJCC v8 | View |
Keywords: